Log in to save to my catalogue

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcom...

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcom...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71497741

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

About this item

Full title

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2002-03, Vol.8 (3), p.225-232

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Treatment with HIV-1 protease inhibitors (PI) is associated with a reduced incidence or regression of Kaposi sarcoma (KS). Here we show that systemic administration of the PIs indinavir or saquinavir to nude mice blocks the development and induces regression of angioproliferative KS-like lesions promoted by primary human KS cells, basic fibroblast...

Alternative Titles

Full title

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_71497741

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71497741

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm0302-225

How to access this item